A case study of 10 patients administered HBOC-201 in high doses over a prolonged period: outcomes during severe anemia when transfusion is not an option.
CONCLUSIONS: Administration of HBOC-201 over an extended period is a feasible and safe oxygen bridge for severely anemic patients who cannot be transfused with RBC.
PMID: 32358832 [PubMed - as supplied by publisher]
Source: Transfusion - Category: Hematology Authors: Zumberg M, Gorlin J, Griffiths EA, Schwartz G, Fletcher BS, Walsh K, Dao KH, Vansandt A, Lynn M, Shander A Tags: Transfusion Source Type: research
More News: Anemia | Emergency Medicine | Gastroenterology | Gorlin syndrome | Hematology | Hypertension | Investigational New Drugs | Study